(Q33269777)

English

Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

0 references

1 reference

Europe PubMed Central

Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Laurie Elit

1

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Thomas K Oliver

2

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Allan Covens

3

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Janice Kwon

4

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Michael Fung-Kee Fung

5

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Holger W Hirte

6

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Amit M Oza

7

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

language of work or name

0 references

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

109

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

692-702

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Epithelial ovarian cancer: a review of current management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on Gynecologic Oncology Group (GOG) trials in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

First-line therapy for ovarian carcinoma: what's next?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal drug delivery of antineoplastics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary toxicity analysis of intraperitoneal carboplatin in combination with intravenous paclitaxel chemotherapy for patients with carcinoma of the ovary, peritoneum, or fallopian tube

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22466

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22466

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33269777&oldid=1773386592"